OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 35
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 35
Showing 26-50 of 35 citing articles:
Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development
Mohamed Reda Halawa, Precious M. Newman, Tope Aderibigbe, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 111029-111029
Open Access
Mohamed Reda Halawa, Precious M. Newman, Tope Aderibigbe, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 111029-111029
Open Access
Therapeutic Peptides in the Treatment of Digestive Inflammation: Current Advances and Future Prospects
Liangliang He, Aijing Li, Ping Yu, et al.
Pharmacological Research (2024), pp. 107461-107461
Open Access
Liangliang He, Aijing Li, Ping Yu, et al.
Pharmacological Research (2024), pp. 107461-107461
Open Access
Machine learning‐based rational design for efficient discovery of allatostatin analogs as promising lead candidates for novel IGRs
Yimeng Zhang, Qi He, Jialin Cui, et al.
Pest Management Science (2024)
Closed Access
Yimeng Zhang, Qi He, Jialin Cui, et al.
Pest Management Science (2024)
Closed Access
The application and prospects of drug delivery systems in idiopathic pulmonary fibrosis
Xi Zhang, Ling Zhang, Jia-Hua Tian, et al.
Biomaterials Advances (2024) Vol. 168, pp. 214123-214123
Closed Access
Xi Zhang, Ling Zhang, Jia-Hua Tian, et al.
Biomaterials Advances (2024) Vol. 168, pp. 214123-214123
Closed Access
Novel drug delivery systems for hirudin-based product development and clinical applications
Li‐Hua Mo, Can Yang, Yu Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138533-138533
Closed Access
Li‐Hua Mo, Can Yang, Yu Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138533-138533
Closed Access
Gemini surfactant-like peptide-based nanocages with β-sheet-enhanced stability and encapsulation efficiency of hydrophobic anticancer drugs
Feng Gao, Xinmin Zhao, Qiankang Si, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12863-12868
Open Access | Times Cited: 1
Feng Gao, Xinmin Zhao, Qiankang Si, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12863-12868
Open Access | Times Cited: 1
The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGF ‐β/Smad signaling pathway
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 1
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 1
Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study
Sarfraz Ahmad, Muhammad Usman Mirza, John F. Trant
(2023)
Open Access
Sarfraz Ahmad, Muhammad Usman Mirza, John F. Trant
(2023)
Open Access
Cancer Treatment With Peptide Therapeutics Peptid terapötikleri ile kanser tedavisi
Emel SAVUL, Berrin Erdağ
AYDIN TIP FAKÜLTESİ KLİNİKLERİ DERGİSİ (2019) Vol. 6, Iss. 3, pp. 193-203
Open Access
Emel SAVUL, Berrin Erdağ
AYDIN TIP FAKÜLTESİ KLİNİKLERİ DERGİSİ (2019) Vol. 6, Iss. 3, pp. 193-203
Open Access
